| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1177/089198870001300403 |
| P698 | PubMed publication ID | 11128058 |
| P2093 | author name string | L Demers | |
| C Wolfson | |||
| S Vida | |||
| M Oremus | |||
| A Perrault | |||
| P2860 | cites work | “Mini-mental state” | Q25938989 |
| Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease | Q27860795 | ||
| Behavior Rating Scale for Dementia: development of test scales and presentation of data for 555 individuals with Alzheimer's disease | Q30586033 | ||
| Review of outcome measurement instruments in Alzheimer's disease drug trials: introduction | Q34112094 | ||
| Review of outcome measurement instruments in Alzheimer's disease drug trials: psychometric properties of global scales | Q34112110 | ||
| Cornell Scale for Depression in Dementia | Q34174895 | ||
| Research diagnostic criteria: rationale and reliability | Q34711463 | ||
| Behavioural disturbances in the demented elderly: phenomenology, pharmacotherapy and behavioural management | Q35653786 | ||
| Minimum Data Set Plus (MDS+) scores compared with scores from five rating scales | Q36795690 | ||
| Consensus Conference on the Methodology of Clinical Trials of "Nootropics", Munich, June 1989. Report of the Consensus Committee | Q37945981 | ||
| The Dementia Signs and Symptoms Scale: A New Scale for Comprehensive Assessment of Psychopathology in Alzheimer's Disease | Q38771218 | ||
| Longitudinal changes in behavioral problems in old age: a study in an adult day care population | Q40869639 | ||
| The depressions of Alzheimer's disease: sorting, pharmacotherapy, and clinical advice | Q40945375 | ||
| Agitated behaviors in the elderly. II. Preliminary results in the cognitively deteriorated | Q41348104 | ||
| The Neuropsychiatric Inventory: assessing psychopathology in dementia patients | Q41471895 | ||
| Clinical features and pharmacologic treatment of behavioral symptoms of Alzheimer's disease | Q41471899 | ||
| The spectrum of behavioral responses to cholinesterase inhibitor therapy in Alzheimer disease | Q41701339 | ||
| Depression in Alzheimer's disease: receiver operating characteristic analysis of the Cornell Scale for Depression in Dementia and the Hamilton Depression Scale | Q43645066 | ||
| A description of agitation in a nursing home | Q43954966 | ||
| A new behavioral assessment scale for geriatric out- and in-patients: the NOSGER (Nurses' Observation Scale for Geriatric Patients). | Q44024551 | ||
| Behavioral disorders in Alzheimer disease: a transcultural perspective | Q47763709 | ||
| Wandering behaviour in community-residing persons with dementia | Q48762530 | ||
| A longitudinal study of Alzheimer's disease: measurement, rate, and predictors of cognitive deterioration. | Q50603103 | ||
| Gender differences in the behavioral manifestations of Alzheimer's disease. | Q51034827 | ||
| Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease. | Q51994294 | ||
| Assessment of behavioral and affective symptoms in Alzheimer's disease. | Q52059786 | ||
| Use of the Cornell scale in nondemented patients. | Q52087327 | ||
| Statistical methods for assessing measurement error (reliability) in variables relevant to sports medicine. | Q52182223 | ||
| Metrifonate treatment of the cognitive deficits of Alzheimer's disease. Metrifonate Study Group. | Q52563586 | ||
| Improved reliability of the Standardized Alzheimer's Disease Assessment Scale (SADAS) compared with the Alzheimer's Disease Assessment Scale (ADAS). | Q52887653 | ||
| Behavioral disturbance in dementia of the Alzheimer's type. | Q53192484 | ||
| A new scale for the assessment of depressed mood in demented patients. | Q53192896 | ||
| A new rating scale for Alzheimer's disease. | Q53197509 | ||
| The Behavior Rating Scale for Dementia of the Consortium to Establish a Registry for Alzheimer's Disease. The Behavioral Pathology Committee of the Consortium to Establish a Registry for Alzheimer's Disease | Q53201306 | ||
| Noncognitive disturbances in Alzheimer's disease: frequency, longitudinal course, and relationship to cognitive symptoms. | Q53220164 | ||
| A comparison of the Cohen-Mansfield agitation inventory with the CERAD behavioral rating scale for dementia in community-dwelling persons with Alzheimer's disease. | Q53225320 | ||
| The Global Deterioration Scale for assessment of primary degenerative dementia | Q57279034 | ||
| Behavioral Syndromes in Alzheimer’s Disease: Description and Correlates | Q57741870 | ||
| P433 | issue | 4 | |
| P921 | main subject | Alzheimer's disease | Q11081 |
| Psychometric Property | Q124708826 | ||
| P304 | page(s) | 181-196 | |
| P577 | publication date | 2000-01-01 | |
| P1433 | published in | Journal of Geriatric Psychiatry and Neurology | Q6295256 |
| P1476 | title | Review of outcome measurement instruments in Alzheimer's disease drug trials: psychometric properties of behavior and mood scales | |
| P478 | volume | 13 |
| Q58452030 | Alzheimer's Disease |
| Q36806644 | Assessment of behavioural and psychological symptoms associated with dementia |
| Q37777202 | Course of neuropsychiatric symptoms in residents with dementia in long-term care institutions: a systematic review |
| Q30704114 | Donepezil and rivastigmine in the treatment of Alzheimer's disease: a best-evidence synthesis of the published data on their efficacy and cost-effectiveness |
| Q51037908 | EFNS guidelines for the diagnosis and management of Alzheimer's disease. |
| Q51888222 | Efficacy of a cognitive training programme for mild cognitive impairment: results of a randomised controlled study. |
| Q30528041 | Elimination of the vesicular acetylcholine transporter in the forebrain causes hyperactivity and deficits in spatial memory and long-term potentiation |
| Q50035857 | IDEA intervention to prevent depressive symptoms and promote well-being in early-stage dementia: protocol for a randomised controlled feasibility study. |
| Q38974408 | Measurement of Neuropsychiatric Symptoms in Clinical Trials Targeting Alzheimer's Disease and Related Disorders |
| Q50926761 | Neuropsychiatric and behavioral symptoms in a community sample of Hispanics with Alzheimer's disease. |
| Q34777695 | Nonpharmacologic treatment of behavioral disturbance in dementia |
| Q36688859 | Outcome measures for Parkinson's disease dementia: a systematic review |
| Q92796886 | Safety and effectiveness of cannabinoids for the treatment of neuropsychiatric symptoms in dementia: a systematic review |
| Q35858684 | The Neuropsychiatric Inventory-Clinician rating scale (NPI-C): reliability and validity of a revised assessment of neuropsychiatric symptoms in dementia. |
| Q26823480 | The merits and problems of Neuropsychiatric Inventory as an assessment tool in people with dementia and other neurological disorders |
| Q64103777 | Variability in the validity and reliability of outcome measures identified in a systematic review to assess treatment efficacy of cognitive enhancers for Alzheimer's Dementia |
Search more.